{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection", "item": "https://www.patentleaderboard.com/patent/8071568"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection

Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection

US Patent 8071568 · Granted Dec 6, 2011

Estimated economic value: $72,647,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic peptide ligands specific for TSLP2024
Compounds2022
2,3-dihydroisoindole-1-carboxamides useful as ROR-gamma modulators2021
Compounds2021
Compounds2020
Compounds2018
Substituted benzofuran compounds and methods of use thereof for the treatment of2017
Heterocyclic-substituted benzofuran derivatives and methods of use thereof for t2017
Tetracyclic heterocycle compounds and methods of use thereof for the treatment o2016
Macrocyclic compounds as antiviral agents2012
Macrocyclic compounds as antiviral agents2012
Pentacyclic indole derivatives as antiviral agents2012